Trending...
- RYFF AND SIMON COWELL-BACKED LOUNGES.TV COLLABORATE TO CONNECT CREATORS TO BRANDS IN THE UK
- ** Introducing *Smart Phone* – A YA Mystery Adventure from the Mysterious Josh Eber **
- Holman United Methodist Church to Host Post-Election Debrief
Patient-founded nonprofit seeks to stimulate innovative research to improve outcomes for patients with ROS1+ cancers.
SACRAMENTO, Calif. - Californer -- The ROS1ders is pleased to issue their 2024 Request for Application (RFA) to study ROS1-positive (ROS1+) cancer. The RFA is open to investigators who hold a doctorate degree and a faculty appointment at an academic or non-profit research institution anywhere in the world.
"While oral targeted therapies are approved to treat ROS1+ cancer, the drugs don't work for everyone, and they eventually stop working. We are committed to investing in research to improve patient outcomes," says Janet Freeman-Daily, MS, Engr, co-founder and president of The ROS1ders.
The ROS1+ Cancer Innovation Award aims to fund high-risk, high-reward projects focused on ROS1+ cancers. The one-year $75,000 seed grant can be used for pre-clinical, translational, or clinical research.
"Seed grants allow for the generation of initial data to support larger research endeavors," said D. Ross Camidge, MD, PhD, Professor of Medicine/Oncology at the University of Colorado and a member of The ROS1ders Scientific Advisory Board. "While some seeds fail, others grow into mighty trees - they can be the seeds of real breakthroughs."
More on The Californer
The award program uses a two-step application process. The deadline for a letter of intent is May 3, 2024. Those invited to submit a full application must provide it by August 4, 2024. For more information, visit https://theros1ders.org/seed-grant-program.
About the ROS1ders
Founded by patients in 2015 and incorporated in 2019, The ROS1ders is the largest global group of patients and family members living with ROS1+ cancer. It seeks to improve outcomes for all ROS1+ cancers through community, education, and research. Membership in their private Facebook group exceeds 1200 people from over 30 countries. The nonprofit is internationally recognized in the oncology and patient advocacy communities as experts in their disease. Its resources include a medically-vetted website and collaboration with international ROS1+ clinicians, researchers and industry. Please visit theros1ders.org to learn more.
More on The Californer
About ROS1+ Cancer
"While oral targeted therapies are approved to treat ROS1+ cancer, the drugs don't work for everyone, and they eventually stop working. We are committed to investing in research to improve patient outcomes," says Janet Freeman-Daily, MS, Engr, co-founder and president of The ROS1ders.
The ROS1+ Cancer Innovation Award aims to fund high-risk, high-reward projects focused on ROS1+ cancers. The one-year $75,000 seed grant can be used for pre-clinical, translational, or clinical research.
"Seed grants allow for the generation of initial data to support larger research endeavors," said D. Ross Camidge, MD, PhD, Professor of Medicine/Oncology at the University of Colorado and a member of The ROS1ders Scientific Advisory Board. "While some seeds fail, others grow into mighty trees - they can be the seeds of real breakthroughs."
More on The Californer
- MAX INVESTIGATION NOTICE: Investigation Launched into MediaAlpha, Inc. and Attorneys Encourage Investors with Substantial Losses or Witnesses with Relevant Information to Contact Law Firm
- California: CHP arrests 64 suspects in first two weeks of San Bernardino surge operation
- Moorpark College Named 2024 Neighborhood Champion Recipient
- New Book Release: The Focused Faith by Dr. Brian S. Bovee – A Timely Guide to Reclaiming Focus
- Mahershala Ali to Receive the Muhammad Ali Voice of Humanity Honor from the Society of Voice Arts and Sciences, Underwritten by Audible
The award program uses a two-step application process. The deadline for a letter of intent is May 3, 2024. Those invited to submit a full application must provide it by August 4, 2024. For more information, visit https://theros1ders.org/seed-grant-program.
About the ROS1ders
Founded by patients in 2015 and incorporated in 2019, The ROS1ders is the largest global group of patients and family members living with ROS1+ cancer. It seeks to improve outcomes for all ROS1+ cancers through community, education, and research. Membership in their private Facebook group exceeds 1200 people from over 30 countries. The nonprofit is internationally recognized in the oncology and patient advocacy communities as experts in their disease. Its resources include a medically-vetted website and collaboration with international ROS1+ clinicians, researchers and industry. Please visit theros1ders.org to learn more.
More on The Californer
- Mercury Insurance Shares Essential Tips for Preparing Your Home for Fall
- Tangent Productions Presents, Southern California Ska Legends 'Long Beach Dub All Stars' in a Pair of Quicky-Selling Shows; Plus More!
- Southeast Community Foundation to Host A Decade of Impact: 10-Year Anniversary Kickoff Benefit
- Licepros Brings Safe, Affordable, and Professional Lice Removal to a Convenient Location in Conroe, TX
- Hollywood's Golden Age Lives in Palm Springs with All About Bette: An Interlude with Bette Davis starring Morgana Shaw and the Voice of Robert Wagner
About ROS1+ Cancer
- ROS1+ cancer is relatively rare, occurring in just 1-2% of non-small cell lung cancer (NSCLC). The incidence is thought to be similar in other types of cancer.
- Biomarker testing for ROS1 fusions is recommended in guidelines for non-small cell lung cancer (NSCLC), but for few other cancers.
- Patients are typically younger than the average NSCLC patient, have adenocarcinoma, and have no smoking history (a smoking history should not exclude patients from biomarker testing or targeted therapies).
- Oral targeted therapies are the recommended first-line treatment for metastatic ROS1+NSCLC and have increased the survival of patients by years. However, these drugs eventually stop working due to acquired resistance. The mechanisms of resistance are not well understood.
Source: The ROS1ders, Inc.
0 Comments
Latest on The Californer
- McClure Films Announces 2nd Unit Preliminary Filming for "EthanAlmighty - the Movie," December 5
- B Corp Certified PPE Supplier Gains 5th Certification
- A Military Family Asks for CalPERS Accountability As The Country Says "Thank You For Your Service"
- Breaking Celebrity News Actor/Influencer Andre Swilley To Attend Tiana's Bayou Adventure Opening
- BK Flooring Services Launches New Website
- All About Bette: An Interlude with Bette Davis Premieres in Palm Springs starring Morgana Shaw and featuring the Voice of Robert Wagner
- SEEAG's Christmas Tree Fundraiser: Proceeds Fund Ag-Education For Kids
- Pause Studio Opens First Franchise Location, Kicking Off National Expansion
- Alten Construction finalizes work on Morello Park Elementary School
- The Common Thread That Unites Us All
- Vera Koo's 'Wisdom and Things' Available in China
- Austin Lane Technologies Marks 25 Years of Innovation with Industry-Leading ALMobile Solution
- A Fight between Good and Evil... A Christmas Tradition!
- New Short Documentary 50 Years And Counting: The Legacy of Hip Hop Culture, Highlights Evolution
- Jacobs to Continue Supporting One of California's Largest Water Reuse Projects
- The World's No.1 Superstar Unleashes Explosive Holiday Anthem "Decorating Christmas"
- TOM HAUSKEN - Living Landscapes: The Art of Perception
- The Ultimate Freedom LIVE 2024 to Empower Entrepreneurs and Professionals with Life, Business, and Wealth Mastery
- "Lymphomaniac: The 10-Year Cancer-versary" Premieres at The Gregangelo Museum on Dec. 11, 2024
- Sick of Junk Leads? Discover Which Life Insurance Leads Are Truly Worth Your Time